HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Alan Menter Selected Research

Interleukin-17 Receptors

9/2018IL-17 inhibitors for psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Alan Menter Research Topics

Disease

17Psoriasis (Pustulosis Palmaris et Plantaris)
02/2022 - 05/2003
3Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2021 - 05/2016
2Body Weight (Weight, Body)
08/2020 - 05/2016
2Psoriatic Arthritis
05/2016 - 04/2006
1Erythema Ab Igne
01/2021
1Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis)
07/2018
1Skin Diseases (Skin Disease)
07/2018
1Blindness (Hysterical Blindness)
05/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2008
1Blepharoptosis (Ptosis, Eyelid)
09/2003
1Headache (Headaches)
09/2003

Drug/Important Bio-Agent (IBA)

5Biological ProductsIBA
02/2021 - 02/2004
3Pharmaceutical PreparationsIBA
02/2021 - 05/2014
2tildrakizumabIBA
02/2021 - 08/2020
2Etanercept (Enbrel)FDA Link
07/2018 - 05/2008
1deucravacitinibIBA
02/2022
1TYK2 Kinase (Tyrosine Kinase 2)IBA
02/2022
1Coal (Coals)IBA
01/2021
1Triglycerides (Triacylglycerol)IBA
08/2020
1CholesterolIBA
08/2020
1Glucose (Dextrose)FDA LinkGeneric
08/2020
1HDL CholesterolIBA
08/2020
1Interleukin-17 ReceptorsIBA
09/2018
1ixekizumabIBA
09/2018
1secukinumabIBA
09/2018
1brodalumabIBA
09/2018
1Monoclonal AntibodiesIBA
09/2018
1InterleukinsIBA
09/2018
1Interleukin-17 (Interleukin 17)IBA
09/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1tofacitinibIBA
05/2016
1Janus Kinase InhibitorsIBA
05/2016
1Clobetasol (Clobetasol Propionate)FDA LinkGeneric
11/2012
1RetinoidsIBA
05/2008
1AcitretinFDA Link
05/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2006
1Adalimumab (Humira)FDA Link
10/2006
1Methotrexate (Mexate)FDA LinkGeneric
02/2004
1Infliximab (Remicade)FDA Link
01/2004
1Botulinum Toxins (Botulinum Toxin)IBA
09/2003
1tazarotene (Tazorac)FDA Link
05/2003

Therapy/Procedure

6Therapeutics
02/2018 - 04/2006
1Biological Therapy
02/2018